Eric J. Small, MD, FASCO, is Professor of Medicine and Urology at the University of California, San Francisco (UCSF), USA, where he is leader of the Prostate Cancer Program, and Deputy Director and Chief Scientific Officer in the Helen Diller Family Comprehensive Cancer Center. He earned a bachelor's degree from Stanford University and a medical degree from Case Western Reserve University School of Medicine. While in medical school, he completed a fellowship in pathology. Professor Small completed post-graduate residency training in internal medicine at Beth Israel Hospital in Boston, USA, and a fellowship in haematology and oncology at UCSF before joining the UCSF faculty.
Professor Small’s patient care and research are focused on prostate cancer, immunotherapy and the mechanisms of resistance to standard therapies, most recently concentrating on the development of treatment-associated small cell/neuroendocrine prostate cancer (t-SCNC).
Professor Small was principal investigator for the Stand Up to Cancer West Coast Prostate Cancer Dream Team and has been involved with the development of a number of therapeutics, including abiraterone, apalutamide, sipuleucel T and ipilumimab. He is a member of the Board of Directors of the American Society of Clinical Oncology (ASCO).
iMR code: EM-04457 - Date of preparation: January 2019